Ligand Pharmaceuticals (LGND) Asset Utilization Ratio (2011 - 2026)

Ligand Pharmaceuticals (LGND) has 16 years of Asset Utilization Ratio data on file, last reported at 0.18 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 9.67% year-over-year to 0.18; the trailing twelve-month figure through Mar 2026 stood at 0.18 (down 9.67% YoY), and the FY2025 full-year result was 0.21, up 10.83% from the prior year.
• Asset Utilization Ratio advanced to 0.18 in Q1 2026, from 0.18 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.26 in Q1 2023 to a low of 0.14 in Q1 2024.
• A 5-year average of 0.19 and a median of 0.19 in 2022 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio slumped 46.27% in 2024 and jumped 41.26% in 2025, its largest moves.
• Tracing LGND's Asset Utilization Ratio over 5 years: stood at 0.22 in 2022, then dropped by 22.05% to 0.17 in 2023, then advanced by 4.45% to 0.18 in 2024, then rose by 0.16% to 0.18 in 2025, then gained by 0.55% to 0.18 in 2026.
• Business Quant data shows LGND's Asset Utilization Ratio at 0.18 in Q1 2026, 0.18 in Q4 2025, and 0.21 in Q3 2025.